ChemoCentryx
CCXI
#3701
Rank
NZ$6.33 B
Marketcap
NZ$88.10
Share price
0.00%
Change (1 day)
34.87%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI.defunct)

Last known market cap: NZ$6.33 Billion

On November 25, 2022 ChemoCentryx had a market cap of NZ$6.33 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$5.88 B57.76%
2021NZ$3.73 B-37.15%
2020NZ$5.93 B67.9%
2019NZ$3.53 B329.36%
2018NZ$0.82 B101.65%
2017NZ$0.40 B-20%
2016NZ$0.51 B-2.34%
2015NZ$0.52 B38.08%
2014NZ$0.37 B25.33%
2013NZ$0.30 B-37.5%
2012NZ$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$923.29 B 14,472.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$258.32 B 3,977.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$600.93 B 9,384.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$315.98 B 4,887.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$47.26 B 646.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$472.94 B 7,364.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$203.43 B 3,110.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$189.97 B 2,898.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$63.11 B 896.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel